Grace Quach MPS[/caption]
Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.
All the new initiatives, funding schemes and Pharmaceutical Benefits Scheme (PBS) listings that kicked into gear on 1 July 2023.
The new Opioid Dependence Treatment Program kicks off on 1 July. Here's the steps you need to take before, during and after the transition.
The 60-day dispensing policy is predicted to have enormous impacts on community pharmacy and vulnerable Australians.
The recent death of a healthy 3-year-old boy from influenza is a reminder of the dangers of the virus and the importance of vaccination.
Climate change is the most pressing health issue of our time. Pharmacists need to recognise and address this before it’s too late.
The aged care on-site pharmacist initiative is set to build on pioneering efforts over at least 5 years and revolutionise the way pharmacists look after older Australians.
More than 3,000 S8 and diazepam tablets prescribed while RTPM was being largely ignored. While doctors were implicated, 14 pharmacists could have been too.
How pharmacists can contribute to reconciliation and healthcare equity by broadening their understanding of cultural safety.
The date has been set for Victoria’s pharmacy prescribing pilot but one key difference sets it apart from other states' trials.
